HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)

Clinical trials for HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) explained in plain language.

Never miss a new study

Get alerted when new HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) trials appear

Sign up with your email to follow new studies for HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 2 Terminated 1

New hope for High-Risk leukemia: testing a gentler bridge to cure

Disease control Not yet recruiting

This study is for adults with a high-risk type of acute myeloid leukemia (AML) who are in remission and planning a stem cell transplant. It compares two different treatments given before the transplant to help keep the cancer from coming back. One treatment uses a newer drug comb…

Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)

Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control

Last updated Mar 11, 2026 14:54 UTC

HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)

Get alerted when new HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) trials appear

New hope for High-Risk leukemia: testing a gentler bridge to cure